FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent
Imaging Technology
JULY 24, 2024
has replaced conventional imaging methods (bone scan, CT scan) as the standard of care after initial diagnosis and biochemical recurrence[5]. million men living with prostate cancer in America have undergone a PSMA-PET imaging scan[6],[7]. 8] Telix ASX disclosure 20 December 2021. [9] Accessed May 2024. [7]
Let's personalize your content